To purchase hard copies of this book, please email:
orders@intechopen.com
Share this page
This book is indexed in
Medicine » Gastroenterology
Inflammatory Bowel Disease - Advances in Pathogenesis and Management
Edited by Sami Karoui, ISBN 978-953-307-891-5, Hard cover, 332 pages, Publisher: InTech, Chapters published January 27, 2012 under CC BY 3.0 license
DOI: 10.5772/1218
This book is dedicated to inflammatory bowel disease, and the authors discuss the advances in the pathogenesis of inflammatory bowel disease, as well as several new parameters involved in the etiopathogeny of Crohn's disease and ulcerative colitis, such as intestinal barrier dysfunction and the roles of TH 17 cells and IL 17 in the immune response in inflammatory bowel disease. The book also focuses on several relevant clinical points, such as pregnancy during inflammatory bowel disease and the health-related quality of life as an end point of the different treatments of the diseases. Finally, advances in management of patients with inflammatory bowel disease are discussed, especially in a complete review of the recent literature.
- Chapter 1
The Role of COX-2 Inhibitors on Experimental Colitis - Chapter 2
Intestinal Barrier Dysfunction: The Primary Driver of IBD? - Chapter 3
Adenosine Receptors: New Targets to Protect Against Tissue Damage in Inflammatory Bowel Symptoms - Chapter 4
Role of Dipeptidyl Peptidase IV/CD26 in Inflammatory Bowel Disease - Chapter 5
The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function - Chapter 6
Pathogenesis of Inflammatory Bowel Diseases - Chapter 7
The Role of Imaging in Inflammatory Bowel Disease Evaluation - Chapter 8
Health-Related Quality of Life in Inflammatory Bowel Disease - Chapter 9
Validation of a Quantitative Determination Method of Paramino-Salicylic Acid by High-Performance Liquid Chromatography and Its Application in Rat Plasma - Chapter 10
Approach to the Management of the Pregnant Inflammatory Bowel Disease Patient: Successful Outcome - Chapter 11
Bone Morphogenetic Proteins and Signaling Pathway in Inflammatory Bowel Disease - Chapter 12
Genetic Differentiation of Fungi of the Genus Candida Isolated from Patients with Inflammatory Bowel Diseases - Chapter 13
A 9-Year Retrospective Study of Hospitalized IBD Patients in Shanghai Rui Jin Hospital - Chapter 14
The Role of Diet, Prebiotic and Probiotic in the Development and Management of Inflammatory Bowel Diseases (IBD) - Chapter 15
The Use of Pomegranate (Punica granatum L.) Phenolic Compounds as Potential Natural Prevention Against IBDs - Chapter 16
Drug Targeting in IBD Treatment – Existing and New Approaches


